Table 4. Cardiovascular events during follow-up according to the angiotype.

Patients, n	Total	Type 1	Type 2A	Type 2B	Type 3	Type 4	p-value
	302 (100)	52 (17.2)	80 (26.5)	69 (22.8)	20 (6.6)	81 (26.8)
28-day cardiovascular events
Hospital stay, days	6 (5-8)	6 (5-7)	7 (5-10)	6 (5-9)	6.5 (5-7)	6 (5-8)	0.490
28-day MACE	31 (10.3)	6 (11.5)	15 (18.8)	3 (4.3)	5 (25)	2 (2.5)	0.030
All-cause death*	1 (0.3)	0	0	0	1 (5.6)	0	0.250
Non-fatal MI*	18 (6)	3 (5.8)	9 (11.3)	2 (2.9)	2 (10)	2 (2.5)	0.166
Any unplanned revascularisation*	16 (5.3)	3 (5.8)	9 (11.3)	2 (2.9)	2 (10)	0 (0)	0.004
Stroke	1 (0.3)	0	0	0	0	1 (1.2)	1
Bleeding events	4 (1.2)	1 (1.9)	2 (2.5)	1 (1.4)	0	0	0.632
Cardiovascular events up to 4 years							(log-rank)
4-year MACE	48 (15.9)	11 (21.2)	20 (25)	6 (8.7)	5 (25)	6 (7.4)	0.083
All-cause death*	1 (0.3)	0	0	0	1 (5)	0	0.411
Non-fatal MI*	36 (11.9)	8 (15.4)	16 (20)	5 (7.25)	4 (20)	3 (3.7)	0.054
Any unplanned revascularisation*	31 (10.3)	8 (15.4)	13 (16.3)	3 (4.4)	2 (10)	5 (6.2)	0.237
Recurrent SCAD	10 (3.3)	2 (3.8)	2 (2.5)	3 (5.2)	1 (5.1)	2 (2.7)	0.899
Stroke	2 (0.7)	0	0	1 (1.8)	0	1 (1.2)	0.980
Data are presented as means±SDs for continuous variables or median±interquartile range if required and numbers (%) for categorical variables. *MACE components. MI: myocardial infarction